4//SEC Filing
PDL BIOPHARMA, INC. 4
Accession 0000882104-16-000249
CIK 0000882104operating
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:16 PM ET
Size
4.6 KB
Accession
0000882104-16-000249
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Disposition to Issuer
Common stock
2016-12-13−1,935→ 234,374 total
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882104
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:16 PM ET
- Size
- 4.6 KB